Alpine Study Results News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alpine Study Results. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alpine Study Results Today - Breaking & Trending Today

Extended Follow-up of ALPINE Randomized Phase 3 Study Confirms Sustained Superior Progression-free Survival of Zanubrutinib Versus Ibrutinib for Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (R/R CLL/SLL)

Published: December 20, 2023

Jennifer R. Brown, MD, PhD, presents data from the extended follow-up of the ALPINE study investigating zanubrutinib in relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma.

Source: onclive.com

Related Topics:

San DiegoUnited StatesJenniferr BrownExtended Follow UpZanubrutinib Versus IbrutinibRefractory Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaPartnership WithAlpine StudyChronic Lymphocytic LeukemiaBtk InhibitorCll TreatmentAlpine TrialAlpine Study DataAlpine Study ResultsAlpine Extended Follow Up